Announce Date | 05/07/2024 |
EPS Normalized Actual | $-0.54307 (Miss by $-0.20307) |
EPS GAAP Actual | $-0.54307 (Miss by $-0.20307) |
Revenue Actual | $0.078559B |
Revenue Surprise | Beat by $78.559M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $0.1412355B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | -0.03 | -271.33 | -0.03 | -0.03 | 1 |
Dec 2024 | -0.34 | -23.94 | -0.34 | -0.34 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2022 (Sep 2022) | -0.43 | -0.43 | 0.078559B | 53.17% | 78.56M |
FQ2 2022 (Jun 2022) | -0.3 | -0.3 | 0.065868B | 76.7% | 65.87M |
FQ3 2021 (Sep 2021) | -0.275092 | -0.275092 | 0.036788B | 100% | 36.79M |
FQ2 2021 (Jun 2021) | -0.25643 | -0.25643 | 0.015344B | 100% | 15.34M |
FQ4 2022 (Dec 2022) | -0.59 | -0.59 | 0.071391B | 33.4% | 71.39M |
FQ4 2021 (Dec 2021) | -0.17965 | -0.17965 | 0.047545B | 100% | 47.55M |
FQ1 2022 (Mar 2022) | -0.51 | -0.51 | 0.046148B | 55.49% | 46.15M |
FQ1 2021 (Mar 2021) | -0.14 | -0.14 | 0.020542B | 100% | 20.54M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0.1412355B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | -0.13 | -- | -0.13747 | -0.12253 | 1 |
FQ3 2025 (Jul 2025) | -0.155 | -- | -0.1639 | -0.1461 | 1 |
FQ2 2025 (Jun 2025) | -0.02 | -- | -0.02 | -0.02 | 0 |
FQ1 2025 (Mar 2025) | -0.06 | -- | -0.06 | -0.06 | 0 |
FQ4 2024 (Oct 2024) | -0.245 | -- | -0.25907 | -0.23093 | 0 |
FQ3 2024 (Jul 2024) | -0.29 | -- | -0.34 | -0.24 | 2 |
FQ2 2024 (Jun 2024) | 1.34259 | 124.58 | 1.34259 | 1.34259 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.12B | -- | 0.12B | 0.13B | 0 |
FQ3 2025 (Jul 2025) | 0.12B | -- | 0.11B | 0.12B | 0 |
FQ2 2025 (Jun 2025) | 0.12B | -- | 0.12B | 0.12B | 0 |
FQ1 2025 (Mar 2025) | 0.12B | -- | 0.12B | 0.12B | 0 |
FQ4 2024 (Oct 2024) | 0.1B | -- | 0.1B | 0.11B | 1 |
FQ3 2024 (Jul 2024) | 0.1B | -- | 0.09B | 0.1B | 2 |
FQ2 2024 (Jun 2024) | 0.14B | 42.06 | 0.14B | 0.14B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | -0.43 | -0.43 | 100% | |
FQ2 2022 (Jun 2022) | -0.3 | -0.3 | 100% | |
FQ3 2021 (Sep 2021) | -0.275092 | -0.275092 | 100% | |
FQ2 2021 (Jun 2021) | -0.25643 | -0.25643 | 100% | |
FQ4 2022 (Dec 2022) | -0.59 | -0.59 | 100% | |
FQ4 2021 (Dec 2021) | -0.17965 | -0.17965 | 100% | |
FQ1 2022 (Mar 2022) | -0.51 | -0.51 | 100% | |
FQ1 2021 (Mar 2021) | -0.14 | -0.14 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | $0B | $0.08B | $78.56M | 100% |
FQ2 2022 (Jun 2022) | $0B | $0.07B | $65.87M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.04B | $36.79M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.02B | $15.34M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0.07B | $71.39M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.05B | $47.55M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.05B | $46.15M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.02B | $20.54M | 100% |